Forte Biosciences, Inc.
FBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $266,909 | $151,852 | $88,456 | $145,192 |
| - Cash | $93,414 | $106,144 | $45,856 | $22,244 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $173,495 | $45,708 | $42,600 | $122,948 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$17 | -$15 | -$13 | -$10 |
| % Margin | – | – | – | – |
| EBITDA | -$17,665 | -$11,564 | -$16,111 | -$7,145 |
| % Margin | – | – | – | – |
| Net Income | -$17,682 | -$11,249 | -$15,656 | -$7,155 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.99 | -0.96 | -1.37 | -1.12 |
| % Growth | -3.1% | 29.9% | -22.3% | – |
| Operating Cash Flow | -$14,000 | -$10,061 | -$10,355 | -$10,009 |
| Capital Expenditures | -$55 | $0 | -$61 | -$31 |
| Free Cash Flow | -$14,055 | -$10,061 | -$10,416 | -$10,040 |